Skip to content

Clinical trials

Phase 3 Breast Neoplasms trials in Ukraine

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 3 Country / region: Ukraine Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20042
20053
20064
20072
20082
20092
20115
20126
20134
20145
20151
20161
20172
20186
20193
20203
20215
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Active, not recruiting8
Terminated6
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche13
Pfizer6
Novartis Pharmaceuticals5
Amgen3
Intarcia Therapeutics3
Eli Lilly and Company2
Merck Sharp & Dohme LLC2
Mylan Inc.2
Pierre Fabre Medicament2
Sandoz2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms59
Neoplasm Metastasis6
Carcinoma, Ductal, Breast3
Carcinoma, Lobular3
Neoplasms, Hormone-Dependent3
Neutropenia3
Triple Negative Breast Neoplasms3
Neoplasms2
Anemia1
Breast Diseases1

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.